Embargo Watch

Keeping an eye on how scientific information embargoes affect news coverage

Rare move? Archives of Internal Medicine lifts embargo early on vena cava filter study after FDA releases report

with one comment

The Archives of Internal Medicine released a study several hours ahead of its scheduled embargo time today because of a related FDA report, according to an email sent to the Archives/JAMA press list a little after noon Eastern today:

Please Note: Because of an FDA announcement earlier today, the following Archives of Internal Medicine study on vena cava filters is for immediate release.



Media Advisory:  To contact William Nicholson, M.D., call Barry Sparks at [xxx] or e-mail [xxx].

Certain Types of Vena Cava Filters May Fracture and Fragment, Causing Potentially Life-Threatening Complications

CHICAGO – Two specific types of vena cava filters, devices used to prevent blood clots from reaching the lungs, appear to have evidence of fracturing inside the body, with some fractured fragments traveling to the heart and causing potentially life-threatening complications, according to a report posted online today that will appear in the November 8 print issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

The study was originally embargoed for 4 p.m. Eastern today. I contacted Jann Ingmire, director of media relations for the journals, to find out more. She responded:

This was an online first paper…so scheduled for an early release anyway (it will appear in the Nov. 8 print issue of Archives of Internal Medicine). We sent it out with the rest of our materials on Thursday.

We didn’t know about the FDA announcement, but it was brought to our attention by a reporter who asked if we could lift the embargo on the Archives paper as it seemed very timely in light of the FDA’s report. Made sense to us, so we lifted the embargo.

The move — which Embargo Watch applauds in the interests of better press coverage — is apparently a rare one. “I can’t remember ever seeing an embargo lift because of the FDA before,” Brian Reid, a former Bloomberg health reporter who now works in PR, told Embargo Watch.


Written by Ivan Oransky

August 9, 2010 at 1:25 pm

Posted in Uncategorized

One Response

Subscribe to comments with RSS.

  1. My goodness. A journal listening to a reporter’s request, deciding it made sense, and lifting an embargo. This could be the first step down a dangerous slippery slope, Why, it could lead to an avalanche of rationality, or worse!

    Bob Finn

    August 9, 2010 at 6:51 pm

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: